Soligenix Announces Poster Presentations from its Gastrointestinal Acute Radiation Syndrome Program at the 2016 Radiation Research Society Meeting

PRINCETON N.J. Oct. 13 2016 PRNewswire Soligenix Inc. OTCQB SNGXD Soligenix or the Company a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need announced today...